Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for AMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 -2.365M
March 31, 2026 -27.14M
December 31, 2025 -83.24M
September 30, 2025 -71.21M
June 30, 2025 -80.23M
March 31, 2025 -61.21M
December 31, 2024 -79.90M
September 30, 2024 -60.47M
June 30, 2024 -80.11M
March 31, 2024 -38.97M
December 31, 2023 363.50M
September 30, 2023 -105.02M
June 30, 2023 -203.29M
March 31, 2023 -44.46M
December 31, 2022 -176.34M
September 30, 2022 -3.835M
June 30, 2022 -174.23M
March 31, 2022 -237.46M
December 31, 2021 -3.665M
September 30, 2021 -0.527M
June 30, 2021 -55.47M
March 31, 2021 24.77M
December 31, 2020 -55.07M
September 30, 2020 -62.44M
June 30, 2020 -127.13M
Date Value
March 31, 2020 456.13M
December 31, 2019 0.159M
September 30, 2019 -52.84M
June 30, 2019 187.50M
March 31, 2019 1.79M
December 31, 2018 -44.26M
September 30, 2018 -36.88M
June 30, 2018 133.63M
March 31, 2018 -14.97M
December 31, 2017 -13.37M
September 30, 2017 -24.95M
June 30, 2017 -26.94M
March 31, 2017 -11.93M
December 31, 2016 -36.13M
September 30, 2016 -26.82M
June 30, 2016 36.27M
March 31, 2016 152.97M
December 31, 2015 4.91M
September 30, 2015 -11.30M
June 30, 2015 -12.56M
March 31, 2015 75.16M
December 31, 2014 19.65M
September 30, 2014 -6.891M
June 30, 2014 -8.79M
March 31, 2014 -2.584M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
InfuSystem Holdings, Inc. -3.396M
Circle8 Group, Inc. --
Cardinal Health, Inc. -487.00M
Centene Corp. -259.00M
McKesson Corp. 394.00M